507 Diacerein alone and in combination with infliximab diminishes cytokine-mediated inflammation in an in vivo -equivalent cell culture psoriasis model by suppressing the pro-inflammatory effects of IL-17A, IL-22, Oncostatin-M, IL-1α, and TNF-α on keratinocytes